Supply of Ulipristal Acetate (Pharmaceutical Product)

The contract involves the manufacture and supply of Ulipristal Acetate, a pharmaceutical product, under commercial item provisions of FAR 12, ensuring compliance with FDA regulations, current Good Manufacturing Practices (cGMP), and National Drug Code (NDC) requirements. The product is to be produced and delivered as a commercial item, meaning it must meet established market standards without requiring unique government specifications. The subcontract is issued under the North American Industry Classification System code 325412, which designates pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency within the Department of Defense. Performance of the contract is not restricted to a specific geographic location, and all deliverables must adhere to federal pharmaceutical standards to ensure safety, consistency, and regulatory approval. The contract does not specify a set-aside designation, indicating it is open to all eligible contractors. The award is linked to a specific Defense Logistics Agency contract number and delivery identifier, and the product will be procured to support government healthcare or distribution needs, likely for use in military or federal medical systems. Supply must be timely and fully compliant with all applicable regulatory and quality control frameworks.